Cardiac mesenchymal cells from failing and nonfailing hearts limit ventricular dilation when administered late after infarction

Although cell therapy-mediated cardiac repair offers promise for treatment/management of heart failure, lack of fundamental understanding of how cell therapy works limits its translational potential. In particular, whether reparative cells from failing hearts differ from cells derived from nonfailin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Physiol Heart Circ Physiol
Autors principals: Audam, Timothy N., Nong, Yibing, Tomlin, Alex, Jurkovic, Andrea, Li, Hong, Zhu, Xiaoping, Long, Bethany W., Zheng, Yi Wei, Weirick, Tyler, Brittian, Kenneth R., Riggs, Daniel W., Gumpert, Anna, Uchida, Shizuka, Guo, Yiru, Wysoczynski, Marcin, Jones, Steven P.
Format: Artigo
Idioma:Inglês
Publicat: American Physiological Society 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7474443/
https://ncbi.nlm.nih.gov/pubmed/32442025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00114.2020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars